The Sentinel of the Cradle: Inside California’s Lifesaving Botulism Unit
The number refers to California Health and Safety Code § 123707 , which governs the Infant Botulism Treatment and Prevention Unit . This unit is responsible for the manufacture, distribution, and licensure of Botulism Immune Globulin Intravenous (Human) , a life-saving treatment for infants.
Governed by California Health and Safety Code § 123707 , the Infant Botulism Treatment and Prevention Unit isn't just a regulatory body—it’s a manufacturer. It is the primary entity authorized to handle the distribution and licensure of Botulism Immune Globulin Intravenous (Human) , often referred to by its trade name, BabyBIG®. 123707
: To ensure rapid response, the department is exempt from standard competitive bidding for the testing and distribution of the treatment.
: Because cases of infant botulism can fluctuate by up to 60% annually , any unspent funds at the end of a fiscal year are automatically carried forward. This "rainy day" provision ensures that when an outbreak occurs, the resources are already in place. The Sentinel of the Cradle: Inside California’s Lifesaving
Below is a feature article written about this unit and its critical mission.
Infant botulism often stems from environmental spores found in soil or honey. For parents, the sudden onset of "floppy baby syndrome" is a nightmare. The unit established by Section 123707 acts as a global safeguard, ensuring that the specialized antibodies needed to neutralize botulinum toxins are always available, tested, and ready for the infants who need them most. It is the primary entity authorized to handle
The law provides this unit with extraordinary flexibility because the stakes are so high. According to the statute: